Search clinical trials for: SOF/VEL/VOX

Total 159614 results

Gilead Sciences

Terminated

Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection

Hepatitis C Virus Infection

Poland, Italy, United Kingdom
University of California, San Francisco
National Institute of Mental Health (NIMH)

Completed

Tel-Me-Box: Testing a New, Real-time Strategies for Monitoring HIV Medication Adherence in India

HIV | Medication Adherence

India
Gilead Sciences

Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor (POLARIS-4)

Hepatitis C Virus Infection

United States, France, United Kingdom, Germany, Canada, Australia, New Zealand, Puerto Rico
Gilead Sciences

Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis (POLARIS-3)

Hepatitis C Virus Infection

United States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Puerto Rico
Gilead Sciences

Completed

Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Hepatitis C Virus Infection

Germany, United States, Australia, United Kingdom, Canada, France, New Zealand
Johns Hopkins University

Completed

deLIVER: Direct Acting Antiviral Effects on the Liver (deLIVER)

HIV | Liver Disease | HCV Coinfection

United States
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy (POLARIS-2)

Hepatitis C

United States, France, United Kingdom, Germany, Canada, Australia, New Zealand, Puerto Rico
Gilead Sciences

Completed

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

Hepatitis C Virus Infection

Korea, Republic of
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy (POLARIS-1)

Hepatitis C

United States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Puerto Rico
Kessler Foundation

Unknown

Pairing Functional Electrical Stimulation (FES) and Volitional Effort Training Promotes Neuroplasticity and Motor Gain

Stroke | Drop Foot
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen

Hepatitis C Virus Infection

United States
Scentech Medical Technologies Ltd

Not yet recruiting

Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study (Cancer)

Colorectal Cancer | Pancreatic Cancer

Israel
Scentech Medical Technologies Ltd

Completed

Detection of COVID-19 Using Breath Analysis - Validation Study.

COVID-19

Israel
Scentech Medical Technologies Ltd

Withdrawn

Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study (Infection)

Infectious Disease

Israel
Gilead Sciences

Terminated

A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

Hepatitis C Virus Infection

France, Spain, United States, Australia, Canada, Germany, United Kingdom, Italy, New Zealand, Puerto Rico
Cambium Medical Technologies LLC
University of Michigan; Duke University; Oregon Health and Science University; Stanford... and other collaborators

Completed

Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease

Dry Eye | Graft-versus-host-disease | Ocular Discomfort

United States
Gilead Sciences

Completed

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

Hepatitis C Virus Infection

United States, Puerto Rico, New Zealand
Gilead Sciences

Completed

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

Hepatitis C Virus Infection

United States, Puerto Rico, New Zealand
Gilead Sciences

Completed

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection (LEPTON)

Chronic Hepatitis C

New Zealand
University of Maryland, Baltimore
Gilead Sciences; Unity Health Care, Inc.

Completed

Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience (RESOLVE)

Chronic Hepatitis C

United States
Veralox Therapeutics

Recruiting

A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Heparin Induced Thrombocytopenia | Thrombocytopenia, Immune

United States
Johns Hopkins University
The Thomas Wilson Sanitarium for Children of Baltimore City

Completed

Parenting Videos In Primary Care

Discipline Practices | Discipline Attitudes

United States
Gilead Sciences

Terminated

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

Hepatitis C Virus Infection

United States, United Kingdom, Australia, Germany, Italy, New Zealand, Belgium, Poland, Russian Federation
Gilead Sciences

Completed

Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

HCV Infection

New Zealand
University of Rochester
Medtronic

Completed

OptiVol for Precision Medical Management of Heart Failure ((OPTIMED-HF))

Ischemic and Non-ischemic Cardiomyopathy

United States
University of Cologne

Completed

Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury (RenPro-II-WINE)

Chronic Renal Failure/ Kidney Disease | Contrast-medium Induced Acute Kidney Injury

Germany
University of New England

Completed

Pain Inhibition With Neuromuscular Electrical Stimulation

Healthy Participants

United States
University of Malaya

Unknown

Taiwan "Aerosol Box" Versus UMMC "Intubation Box"

COVID-19 | Airway

Malaysia
Second Affiliated Hospital of Soochow University

Recruiting

Light Therapy in Parkinson's Disease

Parkinson Disease | Sleep Disorder | Circadian Rhythm Disorders

China
Pfizer

Terminated

A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Hypertension, Pulmonary

Japan
Zonguldak Bulent Ecevit University

Completed

Effect of Different Supralottic Airway Devicess on Optic Nerve Sheath Diameter

Intracranial Pressure Increase | Supraglottic Airway Device | Optic Nerve Sheath Diameter

Turkey
Tau Pnu Medical Co., Ltd.

Recruiting

The Study for Evaluate of Safety and Efficacy of Vein of Marshall RF Ablation

Persistent Atrial Fibrillation

Korea, Republic of
The Third Xiangya Hospital of Central South University

Unknown

High-density Mapping-guided bOx Isolation and subsTrate Ablation (HOT)

Atrial Fibrillation | Atrial Remodeling
Columbia University
Helen Hayes Hospital

Terminated

Mirror Therapy After Stroke: A Dosing Study

Stroke

United States
Aswan University Hospital

Not yet recruiting

Developmental Endothelial Locus-1, Platelet Count, and Soluble P-selectin in Overweight and Obese Subjects

Overweight and Obesity

Egypt
Aveiro University

Completed

Immediate Exercise-Induced Hypoalgesia in Patients With Chronic Low Back Pain

Low Back Pain

Portugal
University of Manitoba
Canadian Paediatric Society; Manitoba Health, Seniors and Active Living

Completed

Evaluation of Safe Sleep for Babies: a Bassinet Distribution and Education Program

Sudden Infant Death

Canada
National Taiwan University Hospital

Unknown

Therapeutic Evaluation of Lower-level Laser for Treating Dentinal Hypersensitivity

Dentinal Hypersensitivity

Taiwan
Veloxis Pharmaceuticals

Completed

A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101

Healthy Volunteers

United States
Hospices Civils de Lyon

Recruiting

Visuo-Vestibular Adaptation in Virtual Reality (VIVRA)

Healthy Person

France
Universiti Kebangsaan Malaysia Medical Centre

Completed

Impact of Covid-19 Aerosol Box On Intubation Success Rate

Intubation; Difficult or Failed

Malaysia
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer (GastroDOC)

Gastric Cancer | Locally Advanced Malignant Neoplasm

Italy
Gilead Sciences

Terminated

A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma

Multiple Myeloma

United States
University Hospital, Angers

Not yet recruiting

Emergency Structured Clinical Examination Training bOX (ECOX)

Emergencies
Fondation Ophtalmologique Adolphe de Rothschild

Not yet recruiting

Identification of Volatile Organic Compounds (VOCs) as Biopredictors of Epileptic Seizures (ICONE)

Epilepsy
Assiut University

Recruiting

ROX Index in Acute Respiratory Failure

Rox Index

Egypt
Hopital Foch

Terminated

Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response (Immuno-VOC)

Lung Cancer, Non-small Cell

France
The Guthrie Clinic

Completed

A Study Comparing Time to Intubate With and Without a Barrier Box

Intubation

United States
Leiden University Medical Center

Completed

The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients (TheBox)

Myocardial Infarction

Netherlands
Inovio Pharmaceuticals

Completed

Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100

Human Papillomavirus (HPV)

Puerto Rico, United States

3

Subscribe